Join us on Tuesday, September 24 at the Rare Disease Research Symposium 2019
at Purchase College! Check out the agenda.
There’ll be a stellar line-up of rare disease researchers and thought-leaders – and our very own CEO,
Dalfoni Banerjee, will present on Lessons In Patient-Centricity From Rare Disease Clinical Trials.
Hope to see you there!
3SixtyPharma Alzheimer's Anti-IgE anti-inflammatory anti-TNF anti-TNF-? B-cell Biosimilar clinical clinical research CNS Communication CT-P13 DEMENTIA FDA gastrointestinal genome GI Inflammation Inflectra infliximab interchangeability investigational JAK inhibitor KTE-C19 Lymphoma oncology patients Pharma Portfolio Management Program Management Project Management rare disease remote Remsima rheumatoid arthritis spondyloarthritis switching Theravance Biopharma virtual w webinar White House White House Office of Management and Budget White House OMB
